Document Detail


High-dose methotrexate during pregnancy: risk of malformations.
MedLine Citation:
PMID:  21180376     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Methotrexate is a cytotoxic and immunosuppressant drug mainly used in oncology and rheumatology. It is sometimes used at high doses to treat unruptured ectopic pregnancy. Methotrexate is teratogenic. Malformations reported after exposure in utero include: abnormalities of the skull and face, limb defects, failure of ossification, and congenital cardiopathy.The risk of malformations is probably dose-dependent and seems to be relatively low at the low weekly doses used in rheumatology. Three cases of malformations have been reported after failure of high-dose methotrexate in pregnancies that were misdiagnosed as ectopic. Two newborns had scoliosis, facial dysmorphism, limb malformations, or cardiopathy.The third newborn had minor malformations. In practice, high-dose methotrexate must only be used to treat ectopic pregnancy if the diagnosis has been confirmed. The woman should be informed of the risks to her unborn child in case of diagnostic error or treatment failure.
Authors:
-
Related Documents :
2010786 - Maternal weight gain, diet and infant birth weight: correlations during adolescent preg...
17069816 - Gestational weight gain differentials in the presence of intimate partner violence.
12846366 - Associations of maternal and umbilical cord hormone concentrations with maternal, gesta...
16682866 - The agreement between the medgem indirect calorimeter and a standard indirect calorimet...
17893646 - Expression of sp1 and klf6 in the developing human cornea.
7947526 - Discordant birthweight and late fetal death in like-sexed and unlike-sexed twin pairs: ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prescrire international     Volume:  19     ISSN:  1167-7422     ISO Abbreviation:  Prescrire Int     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-12-24     Completed Date:  2011-01-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9439295     Medline TA:  Prescrire Int     Country:  France    
Other Details:
Languages:  eng     Pagination:  212-3     Citation Subset:  T    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / etiology*
Female
Folic Acid Antagonists / adverse effects*
Humans
Methotrexate / adverse effects*
Pregnancy
Pregnancy, Ectopic / drug therapy*
Risk
Treatment Failure
Chemical
Reg. No./Substance:
0/Folic Acid Antagonists; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Elderly dementia patients and neuroleptics: excess mortality.
Next Document:  Drug-induced acneiform rash.